New daily pill aims to tame stubborn seizures in tuberous sclerosis
Disease control
Not yet recruiting
This study tests an oral drug, AV078, in people aged 12 and older with tuberous sclerosis complex (TSC) whose seizures are not controlled by standard medications. Participants are randomly assigned to receive AV078 or a placebo for 12 weeks. The goal is to see if AV078 safely red…
Phase: PHASE2 • Sponsor: Aeovian Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 03, 2026 20:42 UTC